Pages that link to "Q48251313"

The following pages link to Survival in progressive supranuclear palsy and frontotemporal dementia (Q48251313):

Displaying 27 items.

• Impact of Aspiration Pneumonia on the Clinical Course of Progressive Supranuclear Palsy: A Retrospective Cohort Study (Q21131719) (← links)
• Multireceptor fingerprints in progressive supranuclear palsy (Q33568690) (← links)
• Myelin oligodendrocyte basic protein and prognosis in behavioral-variant frontotemporal dementia (Q34079305) (← links)
• Predicting functional decline in behavioural variant frontotemporal dementia (Q34538903) (← links)
• A longitudinal study of motor, oculomotor and cognitive function in progressive supranuclear palsy (Q34994716) (← links)
• Core features of frontotemporal dementia recapitulated in progranulin knockout mice (Q35577194) (← links)
• What Is the Life Expectancy in Frontotemporal Lobar Degeneration? (Q37636495) (← links)
• New insights into atypical parkinsonism. (Q37876156) (← links)
• What makes a prognostic biomarker in CNS diseases: strategies for targeted biomarker discovery? Part 2: chronic progressive and relapsing disease. (Q38088747) (← links)
• Frontotemporal lobar degeneration: Pathogenesis, pathology and pathways to phenotype (Q38382217) (← links)
• Survival in a German population with frontotemporal lobar degeneration (Q38481618) (← links)
• Fragile X-associated tremor/ataxia syndrome: phenotypic comparisons with other movement disorders (Q38896237) (← links)
• Estimating the Number of Persons with Frontotemporal Lobar Degeneration in the US Population (Q38939262) (← links)
• Genetic background predicts poor prognosis in frontotemporal lobar degeneration. (Q39784066) (← links)
• Progressive supra-nuclear palsy: frequency of cardinal extrapyramidal features at first presentation (Q40949767) (← links)
• Progressive supranuclear palsy: progression and survival (Q41020865) (← links)
• Poor caregiver mental health predicts mortality of patients with neurodegenerative disease (Q46083852) (← links)
• Retiring the term FTDP-17 as MAPT mutations are genetic forms of sporadic frontotemporal tauopathies. (Q47281403) (← links)
• Mendelian forms of disease and age at onset affect survival in frontotemporal dementia (Q47908840) (← links)
• Measuring disease progression in corticobasal syndrome (Q48738451) (← links)
• Clinical outcomes of two main variants of progressive supranuclear palsy and multiple system atrophy: a prospective natural history study (Q50640064) (← links)
• Frontotemporal Dementia: An Updated Clinician's Guide. (Q53743005) (← links)
• Heritability in frontotemporal tauopathies (Q61809975) (← links)
• Pyramidal system involvement in progressive supranuclear palsy - a clinicopathological correlation (Q64068912) (← links)
• Prognostic importance of apathy in syndromes associated with frontotemporal lobar degeneration (Q64086445) (← links)
• Scales to Assess Clinical Features of Progressive Supranuclear Palsy: MDS Task Force Report. (Q64977554) (← links)
• Survival, effect measures, and impact numbers after dementia diagnosis: a matched cohort study (Q92604197) (← links)